Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Ertunc, Altiok"'
Autor:
Mhd Nawar Alachkar, Anas Alnaimi, Sebastain Reith, Ertunc Altiok, Jörg Schröder, Nikolaus Marx, Mohammad Almalla
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Percutaneous mitral valve repair (PMVR) requires transseptal puncture and results in iatrogenic atrial septal defect (iASD). The impact of persistent iASD was previously investigated. However, data were diverse and inconclusive. 53 patients
Externí odkaz:
https://doaj.org/article/674cafa3703547e888904ca3ace1287b
Autor:
Matthias Rau, Kirsten Thiele, Niels-Ulrik Korbinian Hartmann, Alexander Schuh, Ertunc Altiok, Julia Möllmann, András P. Keszei, Michael Böhm, Nikolaus Marx, Michael Lehrke
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background In the EMPA-REG OUTCOME trial (Empagliflozin Cardiovascular Outcome Event Trial) treatment with the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin significantly reduced heart failure hospitalization (HHF) in patien
Externí odkaz:
https://doaj.org/article/0bfafb3ebec549339276a1d59e86beeb
Autor:
Annemarie Kirschfink, Mhd Nawar Alachkar, Anas Alnaimi, Felix Vogt, Joerg Schroeder, Michael Lehrke, Michael Frick, Sebastian Reith, Nikolaus Marx, Mohammad Almalla, Ertunc Altiok
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276019 (2022)
BackgroundThere are only limited data on patients with diabetes undergoing transcatheter edge-to-edge repair (TEER) in real-world settings. Previous data indicated patients with diabetes to have a worse prognosis. This study sought to evaluate safety
Externí odkaz:
https://doaj.org/article/34c1788954de4031a40e3ce55197ce07
Autor:
Kirsten Thiele, Matthias Rau, Julian Grebe, Niels-Ulrik Korbinian Hartmann, Ertunc Altiok, Michael Böhm, András P. Keszei, Nikolaus Marx, Michael Lehrke
Publikováno v:
Circulation: Cardiovascular Imaging. 16
Autor:
Annemarie Kirschfink, Jörg Schröder, Felix Vogt, Gereon Schälte, Mhd Nawar Alachkar, Mohammad Almalla, Nikolaus Marx, Julian Grebe, Ertunc Altiok, Michael Frick
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:974-982
To evaluate the effect of general anesthesia (GA) on severity of mitral regurgitation (MR) in patients undergoing transcatheter mitral valve repair (TMVR).Retrospective cohort study.Tertiary care university hospital.Fifty consecutive patients with sy
Publikováno v:
Kardiologie up2date. 18:25-44
Autor:
Annemarie Kirschfink, Mhd Nawar Alachkar, Mohammad Almalla, Julian Grebe, Felix Vogt, Jörg Schröder, Michael Frick, Nikolaus Marx, Ertunc Altiok
Publikováno v:
The international journal of cardiovascular imaging 38(6), 1297-1306 (2022). doi:10.1007/s10554-021-02514-7
The international journal of cardiovascular imaging 38(6), 1297-1306 (2022). doi:10.1007/s10554-021-02514-7
Published by Springer, Dordrecht [u.a.]
Published by Springer, Dordrecht [u.a.]
Autor:
Mhd Nawar, Alachkar, Annemarie, Kirschfink, Anas, Alnaimi, Jörg, Schröder, Felix, Vogt, Nikolaus, Marx, Ertunc, Altiok, Mohammad, Almalla
Publikováno v:
J Geriatr Cardiol
OBJECTIVE: To evaluate the safety and efficacy of transcatheter mitral valve repair (TMVR) using MitraClip(®) devices in oldest-old patients compared to younger patients. METHODS: The study retrospectively included 340 consecutive patients who under
Publikováno v:
Dtsch Arztebl Int
BACKGROUND: Chronic subdural hematoma (cSDH) is typically a disease that affects the elderly. Neurosurgical evacuation is generally indicated for hematomas that are wider than the thickness of the skull. The available guidelines do not address the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c15762668c3290ca9541cac1966e82
https://europepmc.org/articles/PMC9277133/
https://europepmc.org/articles/PMC9277133/
Autor:
Mohammad Almalla, Ertunc Altiok
Publikováno v:
Kardiologie up2date. 16:243-256
AbtractWhen bridging anticoagulation, the risk of bleeding - compared to the thromboembolic risk - is often underestimated. Bridging is only indicated in case of high (and possibly moderate) thromboembolic risk. When bridging patients with indication